Skip to content
Companies

Topaz Biosciences

Skin enzymes that target eczema and acne bacteria

Raised to date

$1.4M

of $3.2M offered across 1 Form D filing

Still open
$1.7M
Investors
8
Last filed
Mar 25, 2025

About

Topaz Biosciences, Inc. is a biotechnology company that specializes in developing innovative solutions for skin health, with a strong emphasis on harnessing the potential of the skin microbiome. Established in 2022 and based in Emeryville, California, the company is committed to addressing common skin issues such as eczema and acne through scientifically-backed enzyme technology.

Topaz Biosciences stands out due to its proprietary metagenomics platform, which allows for the discovery of novel enzyme activities that cannot be replicated through conventional methods.

Funding

  • EquityFiled Mar 25, 2025Form D
    $1.4M/ $3.2M

Product

Enzyme Technology for Skin Health

Skin Care

Topaz Biosciences offers a cutting-edge enzyme technology that targets and selectively reduces harmful bacteria on the skin while preserving beneficial strains. This innovative approach is designed to rebalance the skin microbiome, making it particularly effective for individuals suffering from eczema and acne.

  • Selective reduction of harmful bacteria
  • Preservation of beneficial skin microorganisms
  • Clinically proven efficacy for skin conditions

Built for

Skincare and pharmaceutical companies

People on file